Antimalarial Drug Resistance and Implications for the WHO Global Technical Strategy

被引：0
作者：
Matthew M. Ippolito
Kara A. Moser
Jean-Bertin Bukasa Kabuya
Clark Cunningham
Jonathan J. Juliano
机构：
[1] Johns Hopkins University School of Medicine,Divisions of Clinical Pharmacology and Infectious Diseases, Department of Medicine
[2] Johns Hopkins University School of Public Health,The Johns Hopkins Malaria Research Institute
[3] Johns Hopkins University School of Medicine,Department of Pharmacology and Molecular Sciences
[4] University of North Carolina,Institute for Global Health and Infectious Diseases
[5] Tropical Diseases Research Centre,Clinical Research Department
[6] University of North Carolina,School of Medicine
[7] University of North Carolina,Division of Infectious Diseases, Department of Medicine, School of Medicine
[8] University of North Carolina,Curriculum in Genetics and Molecular Biology, School of Medicine
[9] University of North Carolina,Department of Epidemiology, Gillings School of Global Public Health
来源：
Current Epidemiology Reports | 2021年 / 8卷
关键词：
Malaria; Drug resistance; World Health Organization Global Technical Strategy for Malaria;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：46 / 62
页数：16
相关论文
共 1006 条
[1]  
Najera JA(2011)Some lessons for the future from the Global Malaria Eradication Programme (1955-1969) PLoS Med. 8 e1000412-e1e41
[2]  
Gonzalez-Silva M(2020)Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study Lancet Glob Health 8 e1132-1416
[3]  
Alonso PL(2020)The potential public health consequences of COVID-19 on malaria in Africa Nat Med 26 1411-725
[4]  
Hogan AB(2005)South East Asian Quinine Artesunate Malaria Trial g. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial Lancet. 366 717-1657
[5]  
Jewell BL(2010)Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial Lancet. 376 1647-302
[6]  
Sherrard-Smith E(2000)Effects of artesunate-mefloquine combination on incidence of Lancet. 356 297-692
[7]  
Vesga JF(1999) malaria and mefloquine resistance in western Thailand: a prospective study Antimicrob Agents Chemother. 43 690-423
[8]  
Watson OJ(2014)Declining concentrations of dihydroartemisinin in plasma during 5-day oral treatment with artesunate for Falciparum malaria N Engl J Med. 371 411-162
[9]  
Whittaker C(2015)Spread of artemisinin resistance in Malaria Journal 14 359-633
[10]  
Sherrard-Smith E(1934) malaria The Malayan Medical Journal VIII 145-1560
12345678910